WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares gapped down before the market opened on Thursday. The stock had previously closed at $12.78, but opened at $11.70. WuXi Biologics (Cayman) shares last traded at $11.52, with a volume of 2,889 shares.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One research analyst has rated the stock with a Hold rating. According to MarketBeat, the stock presently has a consensus rating of “Hold”.
Read Our Latest Report on WXXWY
WuXi Biologics (Cayman) Stock Down 8.9%
The firm has a fifty day moving average of $12.95 and a two-hundred day moving average of $10.38.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology companies to support the discovery, development and commercial manufacturing of therapies, helping customers advance drug candidates from early research through clinical and commercial production.
Its capabilities include antibody and recombinant protein development, cell-line development, process development, clinical trial material production and large-scale biomanufacturing.
Featured Articles
- Five stocks we like better than WuXi Biologics (Cayman)
- Flywire’s Rapid Growth Faces a Q3 Test—Is Its Stock Already Too Expensive?
- Cologuard Is Working—So Why Isn’t Abbott Stock?
- Micron’s Taiwan Strike: A High-Stakes Fight Over AI Profits
- Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
